Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Temasek buys 41 percent stake in Manipal Health for USD 2 billion

Ruchika Sharma10 April 2023 12:11 PM IST

Bangalore: In the largest deal in the Indian healthcare space, Singapore-based investment firm Temasek has signed definitive agreements to acquire an...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck, Moderna get PRIME scheme designation from EMA for personalized mRNA cancer vaccine, KEYTRUDA combo for adjuvant treatment of High-risk Melanoma

Ruchika Sharma9 April 2023 2:30 PM IST

Melanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells.

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Biocon Academy conducts Graduation Ceremony for 185 students across four programs

Ruchika Sharma9 April 2023 1:00 PM IST

Eight outstanding students who topped their respective batches were awarded 'Gold Medals for Academic Excellence'.

Philips respiratory devices recall classified as most serious by USFDA

Ruchika Sharma9 April 2023 11:30 AM IST

Philips was recalling the machines as some devices were assigned incorrect or duplicate serial numbers during initial programming, the US health...

USFDA concludes inspection at Emcure Pharma Gujarat facility without any observation

Emcure Pharma wins Merit Award at HIV Congress 2023

Ruchika Sharma9 April 2023 10:00 AM IST

Pune: Emcure Pharmaceuticals, a Indian pharmaceutical company, has been felicitated for its contributions to HIV/AIDS research and development at the...

Amrita School of Medicine Faridabad opens its academic doors, to offer 150 MBBS seats this year

Ruchika Sharma8 April 2023 4:39 PM IST

Faridabad: Opening new vistas for medical education in Haryana, Hon’ble Chief Minister Shri. Manohar Lal inaugurated the Amrita School of...

Setback: Merck, Eisai to stop late-stage study of Keytruda plus Lenvima for metastatic melanoma

Ruchika Sharma8 April 2023 2:01 PM IST

They also said another late-stage trial for Keytruda and Lenvima did not meet its main goal of overall survival for treating a type of colorectal or...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio

Ruchika Sharma8 April 2023 1:00 PM IST

Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma's U.S. generic...

Alkem Labs Slapped Rs 2.34 Cr GST Demand in Goa

Alkem Labs Ankleshwar facility clears USFDA inspection

Ruchika Sharma8 April 2023 11:56 AM IST

Mumbai: Through a recent BSE filing, Alkem Labs has informed that the United States Food and Drug Administration (US FDA) has conducted a GMP and...

Torrent Pharma Appoints Former Cipla Global CTO Geena Malhotra as Chief Technology Officer

Torrent Pharma unveils generic version of Keveyis tablets in US

Ruchika Sharma8 April 2023 11:00 AM IST

Dichlorphenamide Tablets are indicated for the treatment of primary hyperkalemic periodic paralysis and related variants.

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

AbbVie plan to withdraw accelerated nods of Imbruvica in US for patients with certain types of blood cancer

Ruchika Sharma7 April 2023 3:30 PM IST

IMBRUVICA is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company and Janssen Biotech, Inc.

AbbVie trims profit forecasts on IPRnD expenses

Ruchika Sharma7 April 2023 2:30 PM IST

United States: AbbVie Inc has lowered its full-year and first-quarter profit expectations, citing a $150 million hit from acquired in-process...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok